Skip to main content
logo
AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
295.95
+5.16 (1.77%)
Oct 30, 2026, 1:01 PM EDT - Market open

AbbVie Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Net Income
3,6136951,8161869381,286-221,5611,3701,3698221,7782,0242392,4733,9499244,4904,044
Depreciation & Amortization
1,8831,9361,9872,0632,0502,0392,1022,0792,1312,0742,0762,2352,2602,1272,1572,2052,0522,0531,979
Loss (Gain) From Sale of Assets
-----------------172--
Asset Writedown & Restructuring Costs
2917441,2653,5278232486,050829371641,6872,180280860243810269145405
Stock-Based Compensation
166444157209179410164181218348125130179313132126107306129
Other Operating Activities
2041,932466-2141,725232-849794997-162-400-1,3761,0221,4651,577-9872,989-811-398
Change in Accounts Receivable
-1,36987162-156-17-1,479387344178-7023392-80-195-416357-611-785-749
Change in Inventory
-143-184-252-56-155-128-64-52-7596-55-273-185-170-17-114-385-112
Change in Accounts Payable
1,202-1,594-5981,730515-6961,247267-1,6993621792,5381,574-4511,278939-190-258174
Change in Other Net Operating Assets
-188-150-65888371-628-10015225284-582109452-167-204-74299-285265
Operating Cash Flow
3,4363,8295,2187,0245,1531,6357,0485,4472,2714,0404,7537,5746,3194,1937,4287,6025,0054,9085,075
Operating Cash Flow Growth (YoY)
-33.32%134.19%-25.96%28.95%126.90%-59.53%48.28%-28.08%-64.06%-3.65%-36.01%-0.37%26.25%-14.57%46.37%-4.20%2.35%0.64%4.55%

Investing Activities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Capital Expenditures
-322-265-329-381-269-235-291-249-241-193-205-219-178-175-213-177-143-162-187
Cash Acquisitions
-824-266-1,161-2,802-940-538-1,792-8,493-843-9,389-553-157-160-353-300-100-209-185-1,065
Investment in Securities
--28-4--12483-13--20-3-23601,39337-1,398-36
Other Investing Activities
-51-43-1-7728381973-5-6-2210-1265170445154143
Investing Cash Flow
-1,197-574-1,463-3,264-1,181-735-1,874-8,256-1,102-9,588-800-369-341-499-4481,286130-1,591-1,145

Financing Activities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Short-Term Debt Issued
-----1,593---5,008---------
Long-Term Debt Issued
-7,991---3,994---14,963-------2,000-
Total Debt Issued
-7,991-5002413,9635,5872,000--19,971-------2,000-
Short-Term Debt Repaid
--2,499--------5,005---------
Long-Term Debt Repaid
------3,026----103----1,351----4,879-
Total Debt Repaid
-2,000-2,499-799-2,016-3,754-3,026-5,762-403-3,348-5,108-1,794-2-1,002-1,351-6,851-2,701-2-4,879-3,752
Net Debt Issued (Repaid)
-2,0005,492-1,299-1,7752092,561-3,762-403-3,34814,863-1,794-2-1,002-1,351-6,851-2,701-2-2,879-3,752
Issuance of Common Stock
--4863--1067101273136486553117012875
Repurchase of Common Stock
-9-1,489-3-4-12-961-358-17-9-1,324-3-4-10-1,955-4-4-9-1,470-131
Common Dividends Paid
-3,070-3,086-2,911-2,911-2,910-2,925-2,752-2,751-2,750-2,772-2,626-2,627-2,625-2,661-2,506-2,504-2,507-2,526-2,314
Other Financing Activities
252-137367132--75-57-64-331-290-326-320-231-225-216
Financing Cash Flow
-5,054919-4,166-4,590-2,710-1,258-6,861-3,072-6,09710,819-4,449-2,661-3,920-6,192-9,634-5,518-2,679-6,972-6,338

Net Cash Flow

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Foreign Exchange Rate Adjustments
-7-1211-8309-468-9-1823-16-10823-59-337-28
Net Cash Flow
-2,8224,162-400-8381,292-349-1,733-5,873-4,9375,253-4734,5282,048-2,490-2,6313,3112,423-3,648-2,436

Free Cash Flow

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
3,1143,5644,8896,6434,8841,4006,7575,1982,0303,8474,5487,3556,1414,0187,2157,4254,8624,7464,888
Free Cash Flow Growth (YoY)
-36.24%154.57%-27.64%27.80%140.59%-63.61%48.57%-29.33%-66.94%-4.26%-36.96%-0.94%26.31%-15.34%47.61%-3.80%3.56%1.22%6.84%
Free Cash Flow Margin
18.33%23.76%29.42%42.11%31.67%10.49%44.74%35.95%14.04%31.25%31.80%52.81%44.29%32.87%47.72%50.13%33.34%35.06%32.84%
Free Cash Flow Per Share
1.762.012.763.752.760.793.822.931.152.172.574.153.472.264.064.182.742.672.75
Levered Free Cash Flow
2,0823,5904,9696,2296,0231,1166,8625,4702,9254,1525,0167,4306,9473,2356,5006,5645,0294,3305,066
Unlevered Free Cash Flow
2,5484,0385,4166,6916,4861,5547,3015,9203,3794,5655,3687,7777,2923,5816,8536,9145,3774,6735,429

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Cash Interest Paid
--3,002---2,811---2,469---2,546---2,712
Cash Income Tax Paid
--3,626---4,100---4,702---2,988---3,648
Change in Working Capital
-2,721-1,922-4731,253-562-2,580-397750-3,3822474432,627554-8118461,499-1,164-1,275-1,084
SEC Filings: 10-K · 10-Q